Safety Profile of Using Ciprofloxacin in Paediatrics: A Systematic Review and Meta-Analysis
- سال انتشار: 1398
- محل انتشار: مجله پزشکی کودکان، دوره: 7، شماره: 3
- کد COI اختصاصی: JR_JPRE-7-3_001
- زبان مقاله: انگلیسی
- تعداد مشاهده: 203
نویسندگان
Paediatric Infectious Diseases Research Centre, Mazandaran University of Medical Sciences, Sari, Iran.
Department of Clinical Pharmacy, Faculty of Pharmacy, Cardiovascular Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Gastrointestinal Cancer Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Department of Paediatrics, Division of Pulmonary, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Paediatric Infectious Diseases Research Centre, Mazandaran University of Medical Sciences, Sari, Iran.
چکیده
Context: The use of ciprofloxacin is contraindicated in children due to safety concerns. Animal studies have revealed that ciprofloxacin can be associated with arthropathy (joint toxicity) in juvenile animals; however, this potential side effect has not been proven in children. Many clinicians still prescribe ciprofloxacin when there is no suitable alternative. In many developing countries, access to the newer generation of antibiotics is either limited or expensive. Therefore, ciprofloxacin is an available and cost-effective alternative that can save lives when necessary. Objective: This study aimed to systemically review the published studies about the safety profile of using ciprofloxacin in children. Data Sources: All relevant studies published from ۱۹۹۰ to ۲۰۱۸ in the Cochrane library, Trip database, ScienceDirect, PubMed, and Google Scholar were collected. Study Selection: We have only considered clinical trials, which included the following keywords: “ciprofloxacin”, “children under ۱۸ years”, and “arthropathy”. Data Extraction: The collected data were analyzed by Comprehensive Meta-Analysis software (CMA.۲). We used random or fixed-effect methods based on the heterogeneity of the results. The heterogeneity was checked by I۲ index and tau-squared. The publication bias was evaluated by the Begg’s test. Results: The obtained data indicated no increased risk of arthropathy after ciprofloxacin use in children on a short-term basis, in comparison to placebo or other antibiotics. Conclusions: Ciprofloxacin is potentially a safe alternative to be used in children under ۱۸ years old when there is no better alternative.کلیدواژه ها
Pediatrics, Ciprofloxacin, Safety profile, Arthropathy, Fluoroquinolonesاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.